ReP USP - Resultado da busca

Artigo de periodico
The NLRP3 inflammasome in stress response: another target for the promiscuous cannabidiol (2023)
Hartmann, Alice; Vila-Verde, Carla ; Guimarães, Francisco Silveira ; Wegener, Sâmia Regiane Lourenço Joca ; Lisboa, Sabrina Francesca de Souza
Source: Current Neuropharmacology. Unidades: FMRP, FCFRP, IRI
Subjects: CANABINOIDES, INFLAMAÇÃO, TECIDO NERVOSO, DEGENERAÇÃO NEURAL, DOENÇAS DO SISTEMA NERVOSO, TRANSTORNOS PSICÓTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HARTMANN, Alice et al. The NLRP3 inflammasome in stress response: another target for the promiscuous cannabidiol. Current Neuropharmacology, v. 21, n. 2, p. 284-308, 2023Tradução . . Disponível em: https://doi.org/10.2174/1570159X20666220411101217. Acesso em: 18 nov. 2024.
APA
Hartmann, A., Vila-Verde, C., Guimarães, F. S., Wegener, S. R. L. J., & Lisboa, S. F. de S. (2023). The NLRP3 inflammasome in stress response: another target for the promiscuous cannabidiol. Current Neuropharmacology, 21( 2), 284-308. doi:10.2174/1570159X20666220411101217
NLM
Hartmann A, Vila-Verde C, Guimarães FS, Wegener SRLJ, Lisboa SF de S. The NLRP3 inflammasome in stress response: another target for the promiscuous cannabidiol [Internet]. Current Neuropharmacology. 2023 ; 21( 2): 284-308.[citado 2024 nov. 18 ] Available from: https://doi.org/10.2174/1570159X20666220411101217
Vancouver
Hartmann A, Vila-Verde C, Guimarães FS, Wegener SRLJ, Lisboa SF de S. The NLRP3 inflammasome in stress response: another target for the promiscuous cannabidiol [Internet]. Current Neuropharmacology. 2023 ; 21( 2): 284-308.[citado 2024 nov. 18 ] Available from: https://doi.org/10.2174/1570159X20666220411101217
Artigo de periodico
DNA methylation in stress and depression:: from biomarker to therapeutics (2021)
Sales, Amanda Juliana; Guimarães, Francisco Silveira ; Wegener, Sâmia Regiane Lourenço Joca
Source: Acta Neuropsychiatrica. Unidades: FMRP, FCFRP
Subjects: ANTIDEPRESSIVOS, BIOMARCADORES, CÉREBRO, METILAÇÃO DE DNA, DEPRESSÃO, REGULAÇÃO GÊNICA, ESTRESSE PSICOLÓGICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SALES, Amanda Juliana e GUIMARÃES, Francisco Silveira e WEGENER, Sâmia Regiane Lourenço Joca. DNA methylation in stress and depression:: from biomarker to therapeutics. Acta Neuropsychiatrica, v. 33, n. 5, p. 217-241, 2021Tradução . . Disponível em: https://doi.org/10.1017/neu.2021.18. Acesso em: 18 nov. 2024.
APA
Sales, A. J., Guimarães, F. S., & Wegener, S. R. L. J. (2021). DNA methylation in stress and depression:: from biomarker to therapeutics. Acta Neuropsychiatrica, 33( 5), 217-241. doi:10.1017/neu.2021.18
NLM
Sales AJ, Guimarães FS, Wegener SRLJ. DNA methylation in stress and depression:: from biomarker to therapeutics [Internet]. Acta Neuropsychiatrica. 2021 ; 33( 5): 217-241.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1017/neu.2021.18
Vancouver
Sales AJ, Guimarães FS, Wegener SRLJ. DNA methylation in stress and depression:: from biomarker to therapeutics [Internet]. Acta Neuropsychiatrica. 2021 ; 33( 5): 217-241.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1017/neu.2021.18
Artigo de periodico
Co-administration of cannabidiol and ketamine induces antidepressant-like effects devoid of hyperlocomotor side-effects (2021)
Sartim, Ariandra Guerini; Marques, J.; Silveira, Kennia Moura; Nunes, Pedro Henrique Gobira; Guimarães, Francisco Silveira ; Wegener, G.; Wegener, Sâmia Regiane Lourenço Joca
Source: Neuropharmacology. Unidades: FMRP, FCFRP
Subjects: ANTIDEPRESSIVOS, COMPORTAMENTO ANIMAL, CANABINOIDES, DEPRESSÃO, HIPOCAMPO, ATIVIDADE MOTORA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SARTIM, Ariandra Guerini et al. Co-administration of cannabidiol and ketamine induces antidepressant-like effects devoid of hyperlocomotor side-effects. Neuropharmacology, v. 195, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2021.108679. Acesso em: 18 nov. 2024.
APA
Sartim, A. G., Marques, J., Silveira, K. M., Nunes, P. H. G., Guimarães, F. S., Wegener, G., & Wegener, S. R. L. J. (2021). Co-administration of cannabidiol and ketamine induces antidepressant-like effects devoid of hyperlocomotor side-effects. Neuropharmacology, 195. doi:10.1016/j.neuropharm.2021.108679
NLM
Sartim AG, Marques J, Silveira KM, Nunes PHG, Guimarães FS, Wegener G, Wegener SRLJ. Co-administration of cannabidiol and ketamine induces antidepressant-like effects devoid of hyperlocomotor side-effects [Internet]. Neuropharmacology. 2021 ; 195[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.neuropharm.2021.108679
Vancouver
Sartim AG, Marques J, Silveira KM, Nunes PHG, Guimarães FS, Wegener G, Wegener SRLJ. Co-administration of cannabidiol and ketamine induces antidepressant-like effects devoid of hyperlocomotor side-effects [Internet]. Neuropharmacology. 2021 ; 195[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.neuropharm.2021.108679
Parte de monografia/livro
Putative effects of cannabidiol in depression and synaptic plasticity (2021)
Wegener, Sâmia Regiane Lourenço Joca ; Silote, Gabriela Pandini; Sartim, Ariandra Guerini; Sales, Amanda Juliana; Guimarães, Francisco Silveira ; Wegener, Gregers
Source: The neuroscience of depression: features, diagnosis, and treatment. Unidades: FCFRP, FMRP
Subjects: CANABINOIDES, DEPRESSÃO, ANSIEDADE, ANTIDEPRESSIVOS, NEUROCIÊNCIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WEGENER, Sâmia Regiane Lourenço Joca et al. Putative effects of cannabidiol in depression and synaptic plasticity. The neuroscience of depression: features, diagnosis, and treatment. Tradução . London: Academic Press, 2021. p. 592 . Disponível em: https://doi.org/10.1016/B978-0-12-817933-8.00052-9. Acesso em: 18 nov. 2024.
APA
Wegener, S. R. L. J., Silote, G. P., Sartim, A. G., Sales, A. J., Guimarães, F. S., & Wegener, G. (2021). Putative effects of cannabidiol in depression and synaptic plasticity. In The neuroscience of depression: features, diagnosis, and treatment (p. 592 ). London: Academic Press. doi:10.1016/B978-0-12-817933-8.00052-9
NLM
Wegener SRLJ, Silote GP, Sartim AG, Sales AJ, Guimarães FS, Wegener G. Putative effects of cannabidiol in depression and synaptic plasticity [Internet]. In: The neuroscience of depression: features, diagnosis, and treatment. London: Academic Press; 2021. p. 592 .[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/B978-0-12-817933-8.00052-9
Vancouver
Wegener SRLJ, Silote GP, Sartim AG, Sales AJ, Guimarães FS, Wegener G. Putative effects of cannabidiol in depression and synaptic plasticity [Internet]. In: The neuroscience of depression: features, diagnosis, and treatment. London: Academic Press; 2021. p. 592 .[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/B978-0-12-817933-8.00052-9
Artigo de periodico
Strain-, sex-, and time-dependent antidepressant-like effects of Cannabidiol (2021)
Silote, Gabriela Pandini ; Gatto, Michelle C.; Eskelund, Amanda; Guimarães, Francisco Silveira ; Wegener, Gregers; Joca, Sâmia Regiane Lourenço
Source: Pharmaceuticals. Unidades: FMRP, FCFRP
Subjects: CANNABIS, ANTIDEPRESSIVOS, MODELOS ANIMAIS DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILOTE, Gabriela Pandini et al. Strain-, sex-, and time-dependent antidepressant-like effects of Cannabidiol. Pharmaceuticals, v. 14, n. 12, p. 1-19, 2021Tradução . . Disponível em: https://doi.org/10.3390/ph14121269. Acesso em: 18 nov. 2024.
APA
Silote, G. P., Gatto, M. C., Eskelund, A., Guimarães, F. S., Wegener, G., & Joca, S. R. L. (2021). Strain-, sex-, and time-dependent antidepressant-like effects of Cannabidiol. Pharmaceuticals, 14( 12), 1-19. doi:10.3390/ph14121269
NLM
Silote GP, Gatto MC, Eskelund A, Guimarães FS, Wegener G, Joca SRL. Strain-, sex-, and time-dependent antidepressant-like effects of Cannabidiol [Internet]. Pharmaceuticals. 2021 ; 14( 12): 1-19.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/ph14121269
Vancouver
Silote GP, Gatto MC, Eskelund A, Guimarães FS, Wegener G, Joca SRL. Strain-, sex-, and time-dependent antidepressant-like effects of Cannabidiol [Internet]. Pharmaceuticals. 2021 ; 14( 12): 1-19.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/ph14121269
Artigo de periodico
Targeting 2‐arachidonoylglycerol signalling in the neurobiology and treatment of depression (2021)
Silveira, Kennia Moura; Wegener, Gregers; Wegener, Sâmia Regiane Lourenço Joca
Source: Basic & Clinical Pharmacology & Toxicology. Unidade: FCFRP
Subjects: ANTIDEPRESSIVOS, ÁCIDOS ARAQUIDÔNICOS, CÉREBRO, DEPRESSÃO, GLICERÍDEOS, CANABINOIDES, TRANSDUÇÃO DE SINAL CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVEIRA, Kennia Moura e WEGENER, Gregers e WEGENER, Sâmia Regiane Lourenço Joca. Targeting 2‐arachidonoylglycerol signalling in the neurobiology and treatment of depression. Basic & Clinical Pharmacology & Toxicology, v. 129, n. 1, p. 3-14, 2021Tradução . . Disponível em: https://doi.org/10.1111/bcpt.13595. Acesso em: 18 nov. 2024.
APA
Silveira, K. M., Wegener, G., & Wegener, S. R. L. J. (2021). Targeting 2‐arachidonoylglycerol signalling in the neurobiology and treatment of depression. Basic & Clinical Pharmacology & Toxicology, 129( 1), 3-14. doi:10.1111/bcpt.13595
NLM
Silveira KM, Wegener G, Wegener SRLJ. Targeting 2‐arachidonoylglycerol signalling in the neurobiology and treatment of depression [Internet]. Basic & Clinical Pharmacology & Toxicology. 2021 ; 129( 1): 3-14.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1111/bcpt.13595
Vancouver
Silveira KM, Wegener G, Wegener SRLJ. Targeting 2‐arachidonoylglycerol signalling in the neurobiology and treatment of depression [Internet]. Basic & Clinical Pharmacology & Toxicology. 2021 ; 129( 1): 3-14.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1111/bcpt.13595

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Source title

Funding Agencies

Indexado em

Non normalized affiliation